Figure 4.
Clinical symptoms of the a-taVNS (N = 26) and s-taVNS (N = 26) groups pre-treatment (A); post-treatment (B); 7 days of follow-up (C); 14 days of follow-up (D). Transcutaneous auricular vagus nerve stimulation (taVNS).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.